Study: Trial Results for New Neurological Drugs Often Go Unpublished

    loading  Checking for direct PDF access through Ovid

Abstract

Results of clinical trials for “stalled” neurological drugs — those which had at least one completed Phase III trial but failed to receive FDA approval — are heavily underreported, found a new study.

Related Topics

    loading  Loading Related Articles